Skip to main content
Premium Trial:

Request an Annual Quote

DakoCytomation s CyAn ADP (Advanced Digital Processing) and Research and Markets Cellular Assays 2004

Premium

DakoCytomation last week said that it has started to ship its new CyAn ADP (Advanced Digital Processing) instrument platform for flow cytometry analysis.

DakoCytomation said that the ADP enables high-speed analysis on a 12 in. X 18 in. X 16 in. (30 cm X 45 cm X 40 cm) footprint, and that the instrument comes with new Summit Software version 4.1. The CyAn is available in three models, each offering an individual laser and color configuration for applications such as stem cell/SP analysis, CD34 enumeration, signal transduction, antigen-specific T-cells, and multi-color immunophenotyping, the company said.


Research and Markets has announced the addition of Cellular Assays 2004 to its collection of life sciences and biotechnology research reports.

The new report includes analysis and end-user perspectives on current cellular assays technologies and applications, Research and Markets said. The report integrates case studies, company profiles, market trends, and challenges and strategic options for cellular assay companies seeking market opportunities, Research and Markets said.

Further information on the report can be obtained by visiting http://www.researchandmarkets.com/reportinfo.asp?cat_id=0&report_id=222230.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.